← Back to all trials
Recruiting
NCT06281080
Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial
Conditions: Bladder Cancer
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: Chinese University of Hong Kong
Location: Prince of Wales Hospital Shatin
Summary
This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.
Eligibility Criteria
Inclusion Criteria:
1. Age between 18 and 75 years
2. Body mass index \
Source: ClinicalTrials.gov (NCT06281080). StuddyBuddy aggregates publicly available trial information.
